cancer

FDA mandates pediatric trials for 200 cancer targets
FDA mandates pediatric trials for 200 cancer targets
BioCentury
FDA
pediatric
clinical trials
oncology
cancer
Flag link:
3 Big Pharma Stocks Racing Along the Road to China
3 Big Pharma Stocks Racing Along the Road to China
Motley Fool
China
cancer
Pfizer
AstraZeneca
JNJ
Flag link:
Standardization Of Drug Compendia That Support Off-Label Use Reimbursement Of Cancer Drugs
Standardization Of Drug Compendia That Support Off-Label Use Reimbursement Of Cancer Drugs
Forbes
off-label
oncology
oncologists
cancer
CMS
Flag link:
VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic
VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic
Xconomy
cancer
VelosBio
Arix Bioscience
Flag link:
Roche aims to improve cancer treatments with DNA blood test
Roche aims to improve cancer treatments with DNA blood test
Pharmaforum
Roche
diagnostics
cancer
personalized medicine
solid tumors
FoundationOne Liquid
Flag link:
Release: AbbVie Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families
Release: AbbVie Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families
BioSpace
AbbVie
cancer
pediatric cancer
philanthropy
Flag link:
Preparing for the incoming wave of biosimilars in oncology
Preparing for the incoming wave of biosimilars in oncology
ESMO Open
biosimilars
oncology
cancer
Flag link:
GSK-backed scientific team at UCSF says they found the immortality switch in cancer cells — and know how to turn it off
GSK-backed scientific team at UCSF says they found the immortality switch in cancer cells — and know how to turn it off
Endpoints
cancer
GSK
R&D
UCSF Medical Center
Flag link:
Atara brings another experienced investigator onto its off-the-shelf CAR-T quest in latest collaboration
Atara brings another experienced investigator onto its off-the-shelf CAR-T quest in latest collaboration
Endpoints
Atara
CAR-T
cancer
Flag link:
28-7 Therapeutics raises $65M for cancer drugs aimed at tumor-suppressing RNA
28-7 Therapeutics raises $65M for cancer drugs aimed at tumor-suppressing RNA
Fierce Biotech
28-7 Therapeutics
microRNA
cancer
venture capital
Flag link:
With big-name backing, a startup launches to match cancer patients with clinical trials
With big-name backing, a startup launches to match cancer patients with clinical trials
Stat
cancer
patients
clinical trials
Driver
Flag link:
Financial disclosure lacking in publication of clinical trials, study finds
Financial disclosure lacking in publication of clinical trials, study finds
Science Daily
oncologists
physicians
physician payments
JAMA
scientific journals
cancer
Flag link:
Sutro Biopharma, Arvinas Are Latest to Tee Up Biotech IPOs
Sutro Biopharma, Arvinas Are Latest to Tee Up Biotech IPOs
Xconomy
biotech
IPOs
Sutro BioPharma
Arvinas
cancer
Flag link:
Magnolia Neurosciences Receives $20 Million CPRIT Grant to Develop Therapies to Treat Chemotherapy-Induced Neurological Conditions
Magnolia Neurosciences Receives $20 Million CPRIT Grant to Develop Therapies to Treat Chemotherapy-Induced Neurological Conditions
CP Wire
Magnolia Neurosciences Corporation
Korysso Therapeutics
cancer
chemotherapy
Flag link:
Computer Program Can Predict How Cancer Tumors Will Respond to Drugs Before Dosing Begins
Computer Program Can Predict How Cancer Tumors Will Respond to Drugs Before Dosing Begins
BioSpace
cancer
oncology
drug development
devices
Flag link:
ASCO and Friends of Cancer Research Draft 5 Guidances for FDA
ASCO and Friends of Cancer Research Draft 5 Guidances for FDA
RAPS.org
ASCO
FDA
cancer
oncology
clinical trials
Friends of Cancer Research
Flag link:
Better U.S. Patient Access To Cancer Drugs Comes At A Price
Better U.S. Patient Access To Cancer Drugs Comes At A Price
Forbes
cancer
Europe
patient access
patients
reimbursement
drug pricing
Flag link:
Regeneron And Bluebird Team To Invent New Cell Therapies For Cancer
Regeneron And Bluebird Team To Invent New Cell Therapies For Cancer
Forbes
Regeneron
Bluebird Bio
CAR-T
drug discovery
gene therapy
cancer
Flag link:
Novartis licenses out unwanted GlaxoSmithKline cancer drugs to Chinese biotech
Novartis licenses out unwanted GlaxoSmithKline cancer drugs to Chinese biotech
Fierce Biotech
Novartis
China
Laekna
cancer
afuresertib
uprosertib
Flag link:
Days after Merck deal, Sutro rolls out $85M E round to fund internal cancer pipeline
Days after Merck deal, Sutro rolls out $85M E round to fund internal cancer pipeline
Endpoints
Sutro BioPharma
cancer
Merck
Flag link:

Pages